NeoImmuneTech Statistics
Total Valuation
NeoImmuneTech has a market cap or net worth of KRW 56.95 billion. The enterprise value is 47.55 billion.
| Market Cap | 56.95B | 
| Enterprise Value | 47.55B | 
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
NeoImmuneTech has 98.87 million shares outstanding.
| Current Share Class | n/a | 
| Shares Outstanding | 98.87M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | 0.96% | 
| Owned by Institutions (%) | n/a | 
| Float | 93.73M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 273.14 | 
| PB Ratio | 2.40 | 
| P/TBV Ratio | 3.16 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -1.37 | 
| EV / Sales | 228.04 | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | -1.30 | 
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.64 | 
| Quick Ratio | 0.91 | 
| Debt / Equity | 0.47 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | -0.30 | 
| Interest Coverage | -14.02 | 
Financial Efficiency
Return on equity (ROE) is -84.05% and return on invested capital (ROIC) is -45.62%.
| Return on Equity (ROE) | -84.05% | 
| Return on Assets (ROA) | -36.15% | 
| Return on Invested Capital (ROIC) | -45.62% | 
| Return on Capital Employed (ROCE) | -133.95% | 
| Revenue Per Employee | 4.01M | 
| Profits Per Employee | -667.29M | 
| Employee Count | 52 | 
| Asset Turnover | 0.00 | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | -106.82M | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has decreased by -60.83% in the last 52 weeks. The beta is 0.61, so NeoImmuneTech's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 | 
| 52-Week Price Change | -60.83% | 
| 50-Day Moving Average | 812.80 | 
| 200-Day Moving Average | 1,082.99 | 
| Relative Strength Index (RSI) | 29.27 | 
| Average Volume (20 Days) | 3,368,976 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
In the last 12 months, NeoImmuneTech had revenue of KRW 208.50 million and -34.70 billion in losses. Loss per share was -350.96.
| Revenue | 208.50M | 
| Gross Profit | 6.06B | 
| Operating Income | -35.09B | 
| Pretax Income | -34.81B | 
| Net Income | -34.70B | 
| EBITDA | -31.13B | 
| EBIT | -35.09B | 
| Loss Per Share | -350.96 | 
Balance Sheet
The company has 20.52 billion in cash and 11.12 billion in debt, giving a net cash position of 9.40 billion or 95.10 per share.
| Cash & Cash Equivalents | 20.52B | 
| Total Debt | 11.12B | 
| Net Cash | 9.40B | 
| Net Cash Per Share | 95.10 | 
| Equity (Book Value) | 23.74B | 
| Book Value Per Share | 240.12 | 
| Working Capital | 14.45B | 
Cash Flow
In the last 12 months, operating cash flow was -35.01 billion and capital expenditures -1.60 billion, giving a free cash flow of -36.61 billion.
| Operating Cash Flow | -35.01B | 
| Capital Expenditures | -1.60B | 
| Free Cash Flow | -36.61B | 
| FCF Per Share | -370.33 | 
Margins
| Gross Margin | n/a | 
| Operating Margin | -16,828.46% | 
| Pretax Margin | -16,693.74% | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
NeoImmuneTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | n/a | 
| Shareholder Yield | n/a | 
| Earnings Yield | -60.93% | 
| FCF Yield | -64.29% | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | n/a |